Category Archives: Featured

IAS 2019: With new data, WHO updates DTG guidelines including women in strong, preferred recommendation

By on .

MEXICO CITY – Responding to expanded data gathered in Botswana and Brazil, and to input from communities of women living with HIV, the World Health Organization announced updated guidelines for the use of dolutegravir, restoring the agency’s recommendation that the antiretroviral medicine with fewer side effects, lower resistance, and quicker viral suppression than alternatives is […]

Communication was Dr. Manasseh Phiri’s prescription for infectious diseases

By on .

Dr. Manasseh Phiri was working at the Centre for Infectious Disease Research in Zambia when I met him 10 years ago, although his days as a practicing physician were well behind him by then. Dispirited by the unrelenting toll of AIDS in his country over the decades before life-saving treatment made it there, when locals […]

With promise to “eliminate the HIV epidemic,” and “defeat AIDS in America and beyond,” administration raises questions about policies

By on .

While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are available today on plans to “eliminate the HIV epidemic,” announced by the president in his State of the Union address last night, and while they raise new questions as […]

PEPFAR partners reveal HIV prevention service cuts from expanded “Mexico City Policy,” as organizations endorse act to end its restrictions

By on .

“Protecting Life in Global Health Assistance” policy, also known as the Global Gag Rule, is hitting services for young women the hardest, survey finds When the Trump administration State Department began to enforce a newly reinstated, and greatly expanded version of the restrictions on health information provided by U.S.-funded overseas organizations known as the “Mexico […]

Senate extends PEPFAR, while funding remains a question

By on .

With a matter-of-fact and unanimous approval of the PEPFAR Extension Act of 2018, a five-year renewal of the U.S. flagship program to combat HIV globally, the U.S. Senate Wednesday evening showed that what was once considered revolutionary, can now be considered routine. Perceptions that efforts to stop the spread of an incurable virus across countries […]

Dolutegravir results in low-resource setting highlight benefits

By on .

A standard of care treatment in high-income settings, the benefits of dolutegravir-based treatments for HIV have been clear, with a built-in barrier to the development of drug-resistance, and a less frequent or severe side effects that interfere with staying on a medicine. But the benefits in low-income countries have been harder to assess, with costs, […]

In Lesotho, where life expectancy is under 50, the last to test for HIV are the hardest to reach

By on .

Clinics for men, adolescent-dedicated sections in existing clinics, and increased support for community-based services are all needed to expand the reach of HIV testing in Lesotho, and offer hope of controlling the epidemic in a country where the virus is responsible for one of the shortest life expectancies in the world, according to a report […]

IDWeek presenter highlights global implications of HIV treatment resistance in Philippines

By on .

Oct. 7, 2017 SAN DIEGO –  Dr. Edsel Salvaña has two posters in the exhibit hall here, each one carrying terrible news from the Philippines, that, if you pause to look at the one he stands in front of, he will cheerfully and concisely explain, has frightening implications well beyond his country. In fact, with […]

Who needs infectious disease docs? Everyone . . .

By on .

Journal supplement delves into the rewards and challenges of chasing bugs no one wants to catch . . . Of all the specialties a young physician can enter, one that offers a career of saving lives and protecting communities, supporting social justice and alleviating suffering, while following questions and finding answers across health systems, neighborhoods […]